title: [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
abstract: The 5-year time course of changes in a tuberculous process was studied in 111 patients with drug-resistant pulmonary tuberculosis. 42% of the patients died from tuberculosis. The activity of tuberculosis was preserved in 23% of the patients. Cure occurred in 30%. Cure was achieved in 72% of the patients in case of Mycobacterium tuberculosis monoresistance and in 13.5% in case of multiple resistance to, on the average, 5 drugs, including isoniazid and rifampicin.
authors.forename: M L
authors.initials: ML
authors.lastname: Khodashova
authors.forename: M V
authors.initials: MV
authors.lastname: Iuditskiĭ
authors.forename: O V
authors.initials: OV
authors.lastname: Semenova
mesh_terms: D000328:Adult; D000368:Aged; D000904:Antibiotics, Antitubercular / Q000008:administration & dosage / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy* / Q000401:mortality; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000401:mortality
chemical_list: D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin